Table 1 Baseline characteristics of SHARP patients included in the cost analysis

Number of patients

1,494

2,228

1,017

2,498

7,246

Men

1,078 (72%)

1,368 (61%)

599 (59%)

1,600 (64%)

4,652 (64%)

Age (years)

62 (11)

65 (12)

63 (12)

61 (12)

63 (12)

Prior vascular disease

189 (13%)

350 (16%)

147 (14%)

428 (17%)

1,116 (15%)

Prior diabetes mellitus

268 (18%)

454 (20%)

169 (17%)

546 (22%)

1,439 (20%)

Current smoker

205 (14%)

276 (12%)

133 (13%)

432 (17%)

1,048 (14%)

Body-mass index (kg/m²)

28.4 (5.3)

28.2 (5.8)

27.5 (5.5)

27.0 (5.9)

27.8 (5.7)

Diastolic blood pressure (mm Hg)

80 (13)

79 (13)

80 (12)

77 (13)

79 (13)

Systolic blood pressure (mm Hg)

138 (20)

138 (20)

141 (20)

137 (24)

138 (21)

Total cholesterol (mmol/L)

5.1 (1.1)

5.1 (1.1)

4.9 (1.2)

4.6 (1.2)

4.9 (1.2)

LDL cholesterol (mmol/L)

3.0 (0.8)

2.9 (0.8)

2.8 (0.9)

2.6 (0.9)

2.8 (0.9)

HDL cholesterol (mmol/L)

1.2 (0.3)

1.2 (0.3)

1.1 (0.3)

1.1 (0.4)

1.1 (0.3)

Triglycerides (mmol/L)

2.3 (1.6)

2.3 (1.4)

2.2 (1.4)

2.3 (1.9)

2.3 (1.6)

Renal status

 On dialysis

-

-

-

2,498 (100%)

2,498 (34%)

  Hemodialysis

-

-

-

2,076 (83%)

2,076 (29%)

  Peritoneal dialysis

-

-

-

422 (17%)

422 (6%)

 Not on dialysis

1,494 (100%)

2,228 (100%)

1,017 (100%)

-

4,739 (65%)

Estimated glomerular filtration rate (mL/min/1.73²)

37.6 (6.5)

22.5 (4.3)

10.8 (2.7)

-

24.8 (10.9)

Urinary albumin:creatinine ratio (mg/g)³

 Median (IQR)

75 (16–328)

155 (36–592)

397 (124–1,204)

-

156 (35–626)

 <30

459 (36%)

426 (22%)

62 (7%)

-

947 (23%)

 ≥30, ≤ 300

496 (38%)

820 (42%)

332 (37%)

-

1,648 (40%)

 >300

336 (26%)

722 (37%)

511 (56%)

-

1,569 (38%)

 Not available

203

260

112

-

584

Region of recruitment

 Europe

1,022 (68%)

1,546 (69%)

730 (72%)

1,779 (71%)

5,083 (70%)

 Australasia

260 (17%)

446 (20%)

187 (18%)

408 (16%)

1,302 (18%)

 North America

212 (14%)

236 (11%)

100 (10%)

311 (12%)

861 (12%)